Cargando…

Association of β2-Agonist Receptor Gene Polymorphisms with Acute Exacerbations of COPD: A Prospective Observational Study

OBJECTIVE: To investigate the relationship between β2-agonist receptor gene polymorphisms and acute exacerbations of chronic obstructive pulmonary disease (COPD). METHODS: Retrospective analysis of 99 patients in the respiratory and critical care unit of Fujian Provincial Hospital from 2018 to 2020....

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Fengfeng, Xu, Nengluan, Zheng, Jianshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484971/ https://www.ncbi.nlm.nih.gov/pubmed/36131785 http://dx.doi.org/10.1155/2022/2711489

Ejemplares similares

Retracted: Association of β2-Agonist Receptor Gene Polymorphisms with Acute Exacerbations of COPD: A Prospective Observational Study
por: International, Emergency Medicine
Publicado: (2023)

Bronchodilators in COPD: Impact of β-agonists and anticholinergics on severe exacerbations and mortality
por: Salpeter, Shelley R
Publicado: (2007)

β(2)-Adrenergic Receptor (ADRB2) Gene Polymorphisms and Risk of COPD Exacerbations: The Rotterdam Study
por: Karimi, Leila, et al.
Publicado: (2019)

The role of combination therapy with corticosteroids and long-acting β(2)-agonists in the prevention of exacerbations in COPD
por: Cazzola, Mario, et al.
Publicado: (2006)

Acute Exacerbation of COPD
por: Lief, Lindsay, et al.
Publicado: (2019)

Acute Exacerbations of COPD
por: Wedzicha, J.A.
Publicado: (2002)

Acute Exacerbations of COPD
por: Wedzicha, Jadwiga A.
Publicado: (2009)

Acute Exacerbation of COPD
por: Pappas, Dominic, et al.
Publicado: (2023)

Impact of a functional polymorphism in the PAR-1 gene promoter in COPD and COPD exacerbations
por: Platé, Manuela, et al.
Publicado: (2014)

Acute Exacerbation and Respiratory InfectionS in COPD (AERIS): protocol for a prospective, observational cohort study
por: Bourne, Simon, et al.
Publicado: (2014)

High use of short-acting β(2)-agonists in COPD is associated with an increased risk of exacerbations and mortality
por: Janson, Christer, et al.
Publicado: (2023)

Oscillococcinum(®) for upper respiratory tract infections and exacerbations in COPD: an observational, prospective study (OXITUNIS)
por: Aouina, Hichem, et al.
Publicado: (2021)

Determining prognosis in acute exacerbation of COPD
por: Flattet, Yves, et al.
Publicado: (2017)

Acute exacerbation of COPD: is it the “stroke of the lungs”?
por: Hillas, Georgios, et al.
Publicado: (2016)

'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study
por: Boer, L. M., et al.
Publicado: (2018)

Recurrent Stress Cardiomyopathy During COPD Exacerbation: Are Beta-adrenergic Agonists Only to Blame?
por: Katsa, Ioanna, et al.
Publicado: (2017)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD
por: Wilkinson, Tom M A, et al.
Publicado: (2017)

Aspiration and severe exacerbations in COPD: a prospective study
por: Cvejic, Lydia, et al.
Publicado: (2021)

Distribution of COPD Comorbidities and Creation of Acute Exacerbation Risk Score: Results from SCICP
por: Ge, Haiyan, et al.
Publicado: (2021)

Nebulized corticosteroids in the management of acute exacerbation of COPD
por: Gaude, G. S., et al.
Publicado: (2010)

Hypophosphatemia of prognostic value in acute exacerbation of COPD
por: Makhoul, N, et al.
Publicado: (2011)

Newer fluoroquinolones in the treatment of acute exacerbations of COPD
por: Patel, Amit, et al.
Publicado: (2006)

Use of azithromycin in the treatment of acute exacerbations of COPD
por: Milstone, Aaron P
Publicado: (2008)

Acute kidney injury in stable COPD and at exacerbation
por: Barakat, MF, et al.
Publicado: (2015)

Fine particulate matter in acute exacerbation of COPD
por: Ni, Lei, et al.
Publicado: (2015)

The inflammasome pathway in stable COPD and acute exacerbations
por: Faner, Rosa, et al.
Publicado: (2016)

The recent advances of phenotypes in acute exacerbations of COPD
por: Zhou, Aiyuan, et al.
Publicado: (2017)

Pneumonic vs Nonpneumonic Acute Exacerbations of COPD
por: Lieberman, David, et al.
Publicado: (2002)

Respiratory Viruses in Adults With Acute Exacerbation of COPD
por: Lieberman, David, et al.
Publicado: (2010)

Reversibility of Hypercapnia after an Acute Exacerbation of COPD
por: Bräunlich, Jens, et al.
Publicado: (2022)

Acute COPD exacerbation treatment with noninvasive ventilation
por: Ralf, Ewert, et al.
Publicado: (2023)

Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study
por: Daubin, Cédric, et al.
Publicado: (2008)

Exacerbation of ozone-induced pulmonary and systemic effects by β(2)-adrenergic and/or glucocorticoid receptor agonist/s
por: Henriquez, Andres R., et al.
Publicado: (2019)

Long-acting muscarinic antagonists vs. long-acting β (2) agonists in COPD exacerbations: a systematic review and meta-analysis
por: Maia, Israel Silva, et al.
Publicado: (2017)

Neutrophil-to-Lymphocyte Ratio Predicts Clinical Outcome of Severe Acute Exacerbation of COPD in Frequent Exacerbators
por: Lu, Fang-Ying, et al.
Publicado: (2021)

Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study
por: Zhang, Jing, et al.
Publicado: (2018)

Haematological and Inflammatory Biomarkers Among Stable COPD and Acute Exacerbations of COPD Patients
por: Ramya, Priya A., et al.
Publicado: (2023)

MRI-assessed diaphragmatic function can predict frequent acute exacerbation of COPD: a prospective observational study based on telehealth-based monitoring system
por: Wei, Shuoshuo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1s905d8vkk5cnnduh3nlgktkko